Potafen 25mg

Diclofenac Potassium 25 mg



Clinical Summary

caution advised in 1st trimester, avoid use starting at 30 wk gestation; risk of embryo-fetal toxicity and death low in 1st trimester based on conflicting human data w/ NSAID class; risk of fetal harm, incl. premature fetal ductus arteriosus closure, starting at 30 wk gestation, based on human data w/ NSAID class and drug's mechanism of action

Individuals of Reproductive Potential

caution advised in female pts trying to conceive, esp. if long-term use; NSAIDs may reversibly delay ovulation during tx based on limited human or animal data and drug's mechanism of action


Clinical Summary

may use while breastfeeding; no known risk of infant harm based on limited human data and drug properties; no human data available to assess effects on milk production

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Potafen 25mg only for the indication prescribed.